Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the University of Oxford-developed product threatens to hamper Europe’s Covid-19 immunisation programme.
The vaccine, subject of an acrimonious tug-of-war between its British-Swedish manufacturer and the European commission last month, is being described by German media as a “shelf warmer” as only about 17% of doses delivered to the country have been administered so far.
